MPM BioImpact LLC Diversified Active

CIK: 0001687078 · Show all filings

Period: Q4 2025 (← Previous)

Filing Date: Feb 17, 2026

Total Value ($000): $873,953 (100.0% shares, 0.0% debt)

Holdings (38)

New Positions (15)

Exited Positions (17)

RNA Avidity Biosciences Inc 3.8%
Value ($000) $33,114 Shares 760,022 Est. Cost $39.95 Unrealized +61.7%
ZLAB Zai Lab Ltd 2.9%
Value ($000) $25,250 Shares 745,060 Est. Cost $26.59 Unrealized
CMPX Compass Therapeutics, Inc. 2.0%
Value ($000) $17,766 Shares 5,075,970 Est. Cost $1.57 Unrealized +193.3%
ALKS Alkermes Plc 1.9%
Value ($000) $16,478 Shares 549,262 Est. Cost $31.51 Unrealized -5.0%
VERA Vera Therapeutics Inc. 1.9%
Value ($000) $16,363 Shares 563,075 Est. Cost $35.17 Unrealized +1.0%
JANX Janux Therapeutics Inc 1.7%
Value ($000) $15,013 Shares 614,282 Est. Cost $39.90 Unrealized -41.1%
SPRY ARS Pharmaceuticals Inc 1.5%
Value ($000) $13,099 Shares 1,303,399 Est. Cost $12.03 Unrealized -19.2%
RARE Ultragenyx Pharmaceutical Inc 1.4%
Value ($000) $11,903 Shares 395,700 Est. Cost $46.13 Unrealized -28.7%
WVE Wave Life Sciences PTE LTD 1.3%
Value ($000) $11,019 Shares 1,505,262 Est. Cost $10.27 Unrealized -1.0%
SLNO Soleno Therapeutics Inc 1.2%
Value ($000) $10,140 Shares 150,000 Est. Cost $74.37 Unrealized -26.3%
SLDB Solid Biosciences Inc 1.2%
Value ($000) $10,085 Shares 1,634,569 Est. Cost $4.28 Unrealized +26.6%
AKBA Akebia Therapeutics Inc 0.9%
Value ($000) $7,887 Shares 2,889,125 Est. Cost $2.75 Unrealized -23.8%
DSGN Design Therapeutics Inc 0.5%
Value ($000) $4,181 Shares 555,187 Est. Cost $5.79 Unrealized +35.3%
RNAC Cartesian Therapeutics Inc 0.4%
Value ($000) $3,884 Shares 380,000 Est. Cost $19.06 Unrealized -57.6%
RAPP Rapport Therapeutics Inc 0.2%
Value ($000) $2,133 Shares 71,807 Est. Cost $17.84 Unrealized +55.1%
Repare Therapeutics, Inc. 0.2%
Value ($000) $1,443 Shares 819,924 Est. Cost $31.02 Unrealized
ASMB Assembly Biosciences Inc 0.1%
Value ($000) $1,015 Shares 39,665 Est. Cost $21.94 Unrealized +46.8%

Decreased Positions (16)

EWTX Edgewise Therapeutics Inc 4.7%
Value ($000) $41,075 (+47.2%) Shares 1,655,256 (-3.8%) Est. Cost $17.71 Unrealized +13.4%
SRPT Sarepta Therapeutics Inc 0.2%
Value ($000) $1,506 (-88.8%) Shares 70,000 (-90.0%) Est. Cost $29.24 Unrealized -27.9%
MDGL Madrigal Pharmaceuticals Inc 6.4%
Value ($000) $56,359 (+22.4%) Shares 96,780 (-3.6%) Est. Cost $328.59 Unrealized +55.4%
TRVI Trevi Therapeutics Inc 4.7%
Value ($000) $41,154 (+32.0%) Shares 3,287,087 (-3.5%) Est. Cost $2.95 Unrealized +291.6%
DYN Dyne Therapeutics, Inc. 3.1%
Value ($000) $27,489 (+50.2%) Shares 1,405,388 (-2.8%) Est. Cost $11.01 Unrealized +72.0%
DBVT DBV Technologies S A 2.2%
Value ($000) $19,109 (+81.2%) Shares 996,825 (-5.5%) Est. Cost $9.15 Unrealized
RCKT Rocket Pharmaceuticals, Inc. 0.6%
Value ($000) $5,567 (-56.3%) Shares 1,586,076 (-59.4%) Est. Cost $9.83 Unrealized -65.2%
RLAY Relay Therapeutics Inc. 2.2%
Value ($000) $18,887 (+58.5%) Shares 2,232,451 (-2.2%) Est. Cost $10.70 Unrealized -33.3%
SNDX Syndax Pharmaceuticals Inc 3.2%
Value ($000) $28,105 (+32.8%) Shares 1,337,702 (-2.8%) Est. Cost $13.09 Unrealized +33.3%
TARS Tarsus Pharmaceuticals Inc 3.1%
Value ($000) $26,928 (+32.7%) Shares 328,869 (-3.7%) Est. Cost $45.00 Unrealized +65.9%
STOK Stoke Therapeutics Inc 2.8%
Value ($000) $24,449 (+31.7%) Shares 770,289 (-2.5%) Est. Cost $13.06 Unrealized +130.2%
PTCT PTC Therapeutics Inc 3.7%
Value ($000) $32,664 (+21.4%) Shares 430,013 (-1.9%) Est. Cost $40.98 Unrealized +77.3%
NTRA Natera Inc 2.5%
Value ($000) $21,432 (+34.6%) Shares 93,551 (-5.4%) Est. Cost $76.08 Unrealized +174.2%
HOWL Werewolf Therapeutics, Inc. 0.1%
Value ($000) $884 (-81.4%) Shares 1,393,557 (-42.1%) Est. Cost $13.70 Unrealized -91.1%
XENE Xenon Pharmaceuticals Inc 2.5%
Value ($000) $21,765 (+7.7%) Shares 485,620 (-3.5%) Est. Cost $37.76 Unrealized +11.2%
CNTX Context Therapeutics Inc 1.8%
Value ($000) $15,699 (+10.2%) Shares 10,679,391 (-27.4%) Est. Cost $1.73 Unrealized -32.5%

Unchanged Positions (1)